The cancer cachexia market is witnessing robust momentum, driven by increasing prevalence of cancer-associated cachexia and rising investment in targeted therapies. Growing recognition of cachexia’s impact on patient survival and quality of life has intensified market focus on innovative treatment options. This industry’s dynamics are shaped by evolving clinical protocols and...